CHO supplementation was effective in decreasing CTX levels from baseline to recovery ( 0.50.1 ng/mL to 0.30.1 ng/mL , p < 0.001 ) , while an increase from 0.40.0 ng/mL to 0.60.0 ng/mL ( p < 0.001 ) was observed in the CON group .